MV Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.22K | Sell |
33
-178
| -84% | -$39K | ﹤0.01% | 569 |
|
|
2025
Q1 | $47.2K | Buy |
211
+6
| +3% | +$1.34K | 0.01% | 310 |
|
|
2024
Q4 | $67.2K | Buy |
205
+5
| +3% | +$1.64K | 0.01% | 267 |
|
|
2024
Q3 | $60K | Buy |
200
+7
| +4% | +$2.1K | 0.01% | 288 |
|
|
2024
Q2 | $63.6K | Buy |
193
+4
| +2% | +$1.32K | 0.01% | 267 |
|
|
2024
Q1 | $74.8K | Buy |
189
+4
| +2% | +$1.58K | 0.01% | 262 |
|
|
2023
Q4 | $65.1K | Sell |
185
-3
| -2% | -$1.06K | 0.01% | 271 |
|
|
2023
Q3 | $70.5K | Buy |
188
+2
| +1% | +$750 | 0.01% | 245 |
|
|
2023
Q2 | $71.1K | Buy |
186
+1
| +0.5% | +$382 | 0.01% | 247 |
|
|
2023
Q1 | $64.1K | Buy |
185
+8
| +5% | +$2.77K | 0.01% | 250 |
|
|
2022
Q4 | $41.7K | Sell |
177
-2
| -1% | -$471 | 0.01% | 247 |
|
|
2022
Q3 | $44K | Buy |
179
+27
| +18% | +$6.64K | 0.01% | 229 |
|
|
2022
Q2 | $46K | Buy |
152
+11
| +8% | +$3.33K | 0.01% | 226 |
|
|
2022
Q1 | $58K | Sell |
141
-2
| -1% | -$823 | 0.01% | 209 |
|
|
2021
Q4 | $67K | Buy |
143
+3
| +2% | +$1.41K | 0.01% | 196 |
|
|
2021
Q3 | $59K | Buy |
140
+6
| +4% | +$2.53K | 0.01% | 198 |
|
|
2021
Q2 | $48K | Buy |
+134
| New | +$48K | 0.01% | 193 |
|